Drug Shortage Report for EDARBI

Last updated on 2020-02-14 History
Report ID 103031
Drug Identification Number 02381389
Brand name EDARBI
Common or Proper name EDARBI
Company Name VALEANT CANADA LP/VALEANT CANADA S.E.C.
Active Ingredient(s) AZILSARTAN MEDOXOMIL
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 28ct
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-06
Estimated end date 2020-02-18
Actual end date
Shortage status Actual shortage
Updated date 2020-02-14
Company comments awaiting documents QA
Health Canada comments
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-02-14 French Compare
v8 2020-02-14 English Compare
v7 2020-02-14 English Compare
v6 2020-02-14 English Compare
v5 2020-01-23 French Compare
v4 2020-01-23 English Compare
v3 2020-01-10 French Compare
v2 2020-01-10 English Compare
v1 2020-01-10 English Compare